{
    "relation": [
        [
            "First Name",
            "Sonya",
            "Jay"
        ],
        [
            "Last Name",
            "Sotak",
            "Bonitt"
        ],
        [
            "Suffix",
            "",
            ""
        ],
        [
            "Covered Official Position (if applicable)",
            "",
            ""
        ],
        [
            "New",
            "",
            ""
        ]
    ],
    "pageTitle": "LD-2 Disclosure Form",
    "title": "",
    "url": "http://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=4219F232-FC27-4FFC-B6AA-7C386C28AA77&filingTypeID=64",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 25,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042989790.89/warc/CC-MAIN-20150728002309-00100-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 218511661,
    "recordOffset": 218503459,
    "tableOrientation": "HORIZONTAL",
    "TableContextTimeStampAfterTable": "{31438=Pending draft oncology, Follow-on biologics (HR 5629, HR 1956, S 623, S 1695, S 1505, HR 1038), Patent Reform (HR 1908, S 1145), 1019=Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page, 20618=Access for uninsured (S 1886 & S 1975), Biosimilares (S 1695 & HR 5629), health care reform, United Kingdom (pricing reform), Italy (health care reform & pricing), Germany (health care reform & pricing), France (health care reform & pricing), funding to fight tuberculosis (HR 5501, S 2731), Follow-on Biologics (S 623 & HR 1956), FDA Reauthorization (HR 3580), Medicare Reimbursement (HR 6331), Patent Reform (HR 1908, S 1145), 38610=Follow-on Biologics (HR 5629, HR 1956, S 623, S 1695, S 1505, HR 1038), Patent Reform (HR 1908, S 1145), 45872=Sunshine Act (S 2029, HR 5605), 12200=Norway IP, Finland IP, Poland (IP), Russa WTO accession (IP), Spain IP, Japan (IP), Korea FTA (IP), China (counterfeiting, IP), ASEAN (regulatory harmonization), Thailand (CLs), Philippines (IP), Intellectual Property Rights Enforcement Act (S. 522), Patent Reform Act (S 1145 & HR 1908), Canada (IP), Mexico (IP), Brazil (IP), Canada Market Access & Drug Safety (S 242), Algeria and Tunisia (IP), Egypt (IP), Saudi Arabia (IP), Per (FTA implementation), Argentina (IP), Chili (IP), European Union (market access) Follow-on biologics (HR 5629, HR 1956, S 623, S 1695, S 1505, HR 1038), IP Rights Enforcement Act (S 522), 34756=Medicare (HR 6331), Follow-on Biologics (HR 5629, HR 1956, S 623, S 1695, S 1505, HR 1038)}",
    "textBeforeTable": "",
    "textAfterTable": "City WASHINGTON State DC Zip Code 20004 Country USA 3. Principal place of business (if different than line 2) City \u00a0 State \u00a0 Zip Code \u00a0 Country \u00a0 4a. Contact Name b. Telephone Number c. E-mail \u00a0Mr. \u00a0JOHN (JAY) BONITT \u00a02023937950 \u00a0jeb@lilly.com 5. Senate ID# \u00a013392-12",
    "hasKeyColumn": true,
    "keyColumnIndex": 0,
    "headerRowIndex": 0
}